GrippeAllemagneV3, Main, Exploration, bibRecord, 000211

Distinction of subtype-specific antibodies against European porcine influenza viruses by indirect ELISA based on recombinant hemagglutinin protein fragment-1.

Identifieur interne : 000211 ( Main/Exploration ); précédent : 000210; suivant : 000212

Distinction of subtype-specific antibodies against European porcine influenza viruses by indirect ELISA based on recombinant hemagglutinin protein fragment-1.

Auteurs : Na Zhao [Allemagne] ; Elke Lange ; Sybille Kubald ; Christian Grund ; Martin Beer ; Timm C. Harder

Source :

Virology journal [ 1743-422X ] ; 2013.

RBID : pubmed:23898799

Descripteurs français

KwdFr :
- Allemagne, Animaux, Anticorps antiviraux (sang), Antigènes viraux (génétique), Glycoprotéine hémagglutinine du virus influenza (génétique), Infections à Orthomyxoviridae (immunologie), Infections à Orthomyxoviridae (médecine vétérinaire), Infections à Orthomyxoviridae (virologie), Maladies des porcs (immunologie), Maladies des porcs (virologie), Protéines de liaison à l'ARN (génétique), Protéines du core viral (génétique), Protéines recombinantes (génétique), Suidae, Test ELISA (), Virus de la grippe A (), Virus de la grippe A (immunologie), Virus de la grippe A (isolement et purification).
MESH :
- génétique : Antigènes viraux, Glycoprotéine hémagglutinine du virus influenza, Protéines de liaison à l'ARN, Protéines du core viral, Protéines recombinantes.
- immunologie : Infections à Orthomyxoviridae, Maladies des porcs, Virus de la grippe A.
- isolement et purification : Virus de la grippe A.
- médecine vétérinaire : Infections à Orthomyxoviridae.
- sang : Anticorps antiviraux.
- virologie : Infections à Orthomyxoviridae, Maladies des porcs.
- Allemagne, Animaux, Suidae, Test ELISA, Virus de la grippe A.
Wicri :
- geographic : Allemagne.

English descriptors

KwdEn :
- Animals, Antibodies, Viral (blood), Antigens, Viral (genetics), Enzyme-Linked Immunosorbent Assay (methods), Germany, Hemagglutinin Glycoproteins, Influenza Virus (genetics), Influenza A virus (classification), Influenza A virus (immunology), Influenza A virus (isolation & purification), Orthomyxoviridae Infections (immunology), Orthomyxoviridae Infections (veterinary), Orthomyxoviridae Infections (virology), RNA-Binding Proteins (genetics), Recombinant Proteins (genetics), Swine, Swine Diseases (immunology), Swine Diseases (virology), Viral Core Proteins (genetics).
MESH :
- chemical , blood : Antibodies, Viral.
- chemical , genetics : Antigens, Viral, Hemagglutinin Glycoproteins, Influenza Virus, RNA-Binding Proteins, Recombinant Proteins, Viral Core Proteins.
- geographic : Germany.
- classification : Influenza A virus.
- immunology : Influenza A virus, Orthomyxoviridae Infections, Swine Diseases.
- isolation & purification : Influenza A virus.
- methods : Enzyme-Linked Immunosorbent Assay.
- veterinary : Orthomyxoviridae Infections.
- virology : Orthomyxoviridae Infections, Swine Diseases.
- Animals, Swine.

Abstract

BACKGROUND

Serological investigations of swine influenza virus infections and epidemiological conclusions thereof are challenging due to the complex and regionally variable pattern of co-circulating viral subtypes and lineages and varying vaccination regimes. Detection of subtype-specific antibodies currently depends on hemagglutination inhibition (HI) assays which are difficult to standardize and unsuitable for large scale investigations.

METHODS

The nucleocapsid protein (NP) and HA1 fragments of the hemagglutinin protein (HA) of five different lineages (H1N1av, H1N1pdm, H1pdmN2, H1N2, H3N2) of swine influenza viruses were bacterially expressed and used as diagnostic antigens in indirect ELISA.

RESULTS

Proteins were co-translationally mono-biotinylated and refolded in vitro into an antigenically authentic conformation. Western blotting and indirect ELISA revealed highly subtype-specific antigenic characteristics of the recombinant HA1 proteins although some cross reactivity especially among antigens of the H1 subtype were evident. Discrimination of antibodies directed against four swine influenza virus subtypes co-circulating in Germany was feasible using the indirect ELISA format.

CONCLUSIONS

Bacterially expressed recombinant NP and HA1 swine influenza virus proteins served as antigens in indirect ELISAs and provided an alternative to commercial blocking NP ELISA and HI assays concerning generic (NP-specific) and HA subtype-specific sero-diagnostics, respectively, on a herd basis.

DOI: 10.1186/1743-422X-10-246
PubMed: 23898799

Affiliations:

Allemagne

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000190
to stream Main, to step Curation: 000190

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Distinction of subtype-specific antibodies against European porcine influenza viruses by indirect ELISA based on recombinant hemagglutinin protein fragment-1.</title>
<author><name sortKey="Zhao, Na" sort="Zhao, Na" uniqKey="Zhao N" first="Na" last="Zhao">Na Zhao</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Suedufer 10, Greifswald 17493, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Suedufer 10, Greifswald 17493</wicri:regionArea>
<wicri:noRegion>17493</wicri:noRegion>
<wicri:noRegion>17493</wicri:noRegion>
<wicri:noRegion>Greifswald 17493</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lange, Elke" sort="Lange, Elke" uniqKey="Lange E" first="Elke" last="Lange">Elke Lange</name>
</author>
<author><name sortKey="Kubald, Sybille" sort="Kubald, Sybille" uniqKey="Kubald S" first="Sybille" last="Kubald">Sybille Kubald</name>
</author>
<author><name sortKey="Grund, Christian" sort="Grund, Christian" uniqKey="Grund C" first="Christian" last="Grund">Christian Grund</name>
</author>
<author><name sortKey="Beer, Martin" sort="Beer, Martin" uniqKey="Beer M" first="Martin" last="Beer">Martin Beer</name>
</author>
<author><name sortKey="Harder, Timm C" sort="Harder, Timm C" uniqKey="Harder T" first="Timm C" last="Harder">Timm C. Harder</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23898799</idno>
<idno type="pmid">23898799</idno>
<idno type="doi">10.1186/1743-422X-10-246</idno>
<idno type="wicri:Area/Main/Corpus">000190</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000190</idno>
<idno type="wicri:Area/Main/Curation">000190</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000190</idno>
<idno type="wicri:Area/Main/Exploration">000190</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Distinction of subtype-specific antibodies against European porcine influenza viruses by indirect ELISA based on recombinant hemagglutinin protein fragment-1.</title>
<author><name sortKey="Zhao, Na" sort="Zhao, Na" uniqKey="Zhao N" first="Na" last="Zhao">Na Zhao</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Suedufer 10, Greifswald 17493, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Suedufer 10, Greifswald 17493</wicri:regionArea>
<wicri:noRegion>17493</wicri:noRegion>
<wicri:noRegion>17493</wicri:noRegion>
<wicri:noRegion>Greifswald 17493</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lange, Elke" sort="Lange, Elke" uniqKey="Lange E" first="Elke" last="Lange">Elke Lange</name>
</author>
<author><name sortKey="Kubald, Sybille" sort="Kubald, Sybille" uniqKey="Kubald S" first="Sybille" last="Kubald">Sybille Kubald</name>
</author>
<author><name sortKey="Grund, Christian" sort="Grund, Christian" uniqKey="Grund C" first="Christian" last="Grund">Christian Grund</name>
</author>
<author><name sortKey="Beer, Martin" sort="Beer, Martin" uniqKey="Beer M" first="Martin" last="Beer">Martin Beer</name>
</author>
<author><name sortKey="Harder, Timm C" sort="Harder, Timm C" uniqKey="Harder T" first="Timm C" last="Harder">Timm C. Harder</name>
</author>
</analytic>
<series><title level="j">Virology journal</title>
<idno type="eISSN">1743-422X</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antibodies, Viral (blood)</term>
<term>Antigens, Viral (genetics)</term>
<term>Enzyme-Linked Immunosorbent Assay (methods)</term>
<term>Germany</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (genetics)</term>
<term>Influenza A virus (classification)</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza A virus (isolation & purification)</term>
<term>Orthomyxoviridae Infections (immunology)</term>
<term>Orthomyxoviridae Infections (veterinary)</term>
<term>Orthomyxoviridae Infections (virology)</term>
<term>RNA-Binding Proteins (genetics)</term>
<term>Recombinant Proteins (genetics)</term>
<term>Swine</term>
<term>Swine Diseases (immunology)</term>
<term>Swine Diseases (virology)</term>
<term>Viral Core Proteins (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Allemagne</term>
<term>Animaux</term>
<term>Anticorps antiviraux (sang)</term>
<term>Antigènes viraux (génétique)</term>
<term>Glycoprotéine hémagglutinine du virus influenza (génétique)</term>
<term>Infections à Orthomyxoviridae (immunologie)</term>
<term>Infections à Orthomyxoviridae (médecine vétérinaire)</term>
<term>Infections à Orthomyxoviridae (virologie)</term>
<term>Maladies des porcs (immunologie)</term>
<term>Maladies des porcs (virologie)</term>
<term>Protéines de liaison à l'ARN (génétique)</term>
<term>Protéines du core viral (génétique)</term>
<term>Protéines recombinantes (génétique)</term>
<term>Suidae</term>
<term>Test ELISA ()</term>
<term>Virus de la grippe A ()</term>
<term>Virus de la grippe A (immunologie)</term>
<term>Virus de la grippe A (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, Viral</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
<term>RNA-Binding Proteins</term>
<term>Recombinant Proteins</term>
<term>Viral Core Proteins</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes viraux</term>
<term>Glycoprotéine hémagglutinine du virus influenza</term>
<term>Protéines de liaison à l'ARN</term>
<term>Protéines du core viral</term>
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à Orthomyxoviridae</term>
<term>Maladies des porcs</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term>
<term>Orthomyxoviridae Infections</term>
<term>Swine Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Enzyme-Linked Immunosorbent Assay</term>
</keywords>
<keywords scheme="MESH" qualifier="médecine vétérinaire" xml:lang="fr"><term>Infections à Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="veterinary" xml:lang="en"><term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à Orthomyxoviridae</term>
<term>Maladies des porcs</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Orthomyxoviridae Infections</term>
<term>Swine Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Swine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Allemagne</term>
<term>Animaux</term>
<term>Suidae</term>
<term>Test ELISA</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>Serological investigations of swine influenza virus infections and epidemiological conclusions thereof are challenging due to the complex and regionally variable pattern of co-circulating viral subtypes and lineages and varying vaccination regimes. Detection of subtype-specific antibodies currently depends on hemagglutination inhibition (HI) assays which are difficult to standardize and unsuitable for large scale investigations.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>The nucleocapsid protein (NP) and HA1 fragments of the hemagglutinin protein (HA) of five different lineages (H1N1av, H1N1pdm, H1pdmN2, H1N2, H3N2) of swine influenza viruses were bacterially expressed and used as diagnostic antigens in indirect ELISA.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Proteins were co-translationally mono-biotinylated and refolded in vitro into an antigenically authentic conformation. Western blotting and indirect ELISA revealed highly subtype-specific antigenic characteristics of the recombinant HA1 proteins although some cross reactivity especially among antigens of the H1 subtype were evident. Discrimination of antibodies directed against four swine influenza virus subtypes co-circulating in Germany was feasible using the indirect ELISA format.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>Bacterially expressed recombinant NP and HA1 swine influenza virus proteins served as antigens in indirect ELISAs and provided an alternative to commercial blocking NP ELISA and HI assays concerning generic (NP-specific) and HA subtype-specific sero-diagnostics, respectively, on a herd basis.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23898799</PMID>
<DateCompleted><Year>2014</Year>
<Month>01</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>10</Volume>
<PubDate><Year>2013</Year>
<Month>Jul</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Virology journal</Title>
<ISOAbbreviation>Virol. J.</ISOAbbreviation>
</Journal>
<ArticleTitle>Distinction of subtype-specific antibodies against European porcine influenza viruses by indirect ELISA based on recombinant hemagglutinin protein fragment-1.</ArticleTitle>
<Pagination><MedlinePgn>246</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/1743-422X-10-246</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Serological investigations of swine influenza virus infections and epidemiological conclusions thereof are challenging due to the complex and regionally variable pattern of co-circulating viral subtypes and lineages and varying vaccination regimes. Detection of subtype-specific antibodies currently depends on hemagglutination inhibition (HI) assays which are difficult to standardize and unsuitable for large scale investigations.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The nucleocapsid protein (NP) and HA1 fragments of the hemagglutinin protein (HA) of five different lineages (H1N1av, H1N1pdm, H1pdmN2, H1N2, H3N2) of swine influenza viruses were bacterially expressed and used as diagnostic antigens in indirect ELISA.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Proteins were co-translationally mono-biotinylated and refolded in vitro into an antigenically authentic conformation. Western blotting and indirect ELISA revealed highly subtype-specific antigenic characteristics of the recombinant HA1 proteins although some cross reactivity especially among antigens of the H1 subtype were evident. Discrimination of antibodies directed against four swine influenza virus subtypes co-circulating in Germany was feasible using the indirect ELISA format.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Bacterially expressed recombinant NP and HA1 swine influenza virus proteins served as antigens in indirect ELISAs and provided an alternative to commercial blocking NP ELISA and HI assays concerning generic (NP-specific) and HA subtype-specific sero-diagnostics, respectively, on a herd basis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName>
<ForeName>Na</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Suedufer 10, Greifswald 17493, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lange</LastName>
<ForeName>Elke</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kubald</LastName>
<ForeName>Sybille</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Grund</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Beer</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Harder</LastName>
<ForeName>Timm C</ForeName>
<Initials>TC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>07</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Virol J</MedlineTA>
<NlmUniqueID>101231645</NlmUniqueID>
<ISSNLinking>1743-422X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019267">Hemagglutinin Glycoproteins, Influenza Virus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C048842">NP protein, Influenza A virus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014758">Viral Core Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000956" MajorTopicYN="Y">Antigens, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019267" MajorTopicYN="Y">Hemagglutinin Glycoproteins, Influenza Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016601" MajorTopicYN="Y">RNA-Binding Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013553" MajorTopicYN="N">Swine Diseases</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014758" MajorTopicYN="Y">Viral Core Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>04</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>07</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23898799</ArticleId>
<ArticleId IdType="pii">1743-422X-10-246</ArticleId>
<ArticleId IdType="doi">10.1186/1743-422X-10-246</ArticleId>
<ArticleId IdType="pmc">PMC3733666</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Anim Health Res Rev. 2011 Dec;12(2):133-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22152290</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2011 Aug 5;29(34):5657-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21704111</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2012 Aug 31;30(40):5830-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22835742</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Anim Health Res Rev. 2012 Dec;13(2):181-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23253165</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vet Microbiol. 2013 Mar 23;162(2-4):543-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23201246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Vet Diagn Invest. 2013 Jan;25(1):45-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23166185</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2013;370:133-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22234411</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2013;370:85-112</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22566130</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Transbound Emerg Dis. 2012 Mar;59 Suppl 1:68-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22226050</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2011;8:434</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21902821</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vet Microbiol. 2003 Feb 25;91(4):295-308</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12477644</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Sci. 1999 Apr;8(4):921-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10211839</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Biotechnol. 1999 Oct;17(10):1030-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10504710</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Virol. 2006 Jan;151(1):23-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16132180</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2008 Dec;36(21):e139</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18832366</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Vet Diagn Invest. 2009 Jan;21(1):88-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19139506</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2009 Sep;90(Pt 9):2119-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19592456</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Vet Diagn Invest. 2010 Jan;22(1):3-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20093676</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2010;5(2):e9068</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20140096</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Genet Evol. 2011 Mar;11(2):437-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21163369</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2011 Apr;173(1):49-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21237207</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zoonoses Public Health. 2009 Aug;56(6-7):326-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19486316</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2011 May;92(Pt 5):1184-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21307227</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmeur Bio Sci Notes. 2011 Jun;2011(1):36-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21619855</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2011 Jul;5(4):276-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21651738</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Rev Anti Infect Ther. 2011 Jun;9(6):669-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21692672</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2012 Aug;93(Pt 8):1658-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22622326</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
</list>
<tree><noCountry><name sortKey="Beer, Martin" sort="Beer, Martin" uniqKey="Beer M" first="Martin" last="Beer">Martin Beer</name>
<name sortKey="Grund, Christian" sort="Grund, Christian" uniqKey="Grund C" first="Christian" last="Grund">Christian Grund</name>
<name sortKey="Harder, Timm C" sort="Harder, Timm C" uniqKey="Harder T" first="Timm C" last="Harder">Timm C. Harder</name>
<name sortKey="Kubald, Sybille" sort="Kubald, Sybille" uniqKey="Kubald S" first="Sybille" last="Kubald">Sybille Kubald</name>
<name sortKey="Lange, Elke" sort="Lange, Elke" uniqKey="Lange E" first="Elke" last="Lange">Elke Lange</name>
</noCountry>
<country name="Allemagne"><noRegion><name sortKey="Zhao, Na" sort="Zhao, Na" uniqKey="Zhao N" first="Na" last="Zhao">Na Zhao</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000211 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000211 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeAllemagneV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:23898799
   |texte=   Distinction of subtype-specific antibodies against European porcine influenza viruses by indirect ELISA based on recombinant hemagglutinin protein fragment-1.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23898799" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 11:47:10 2020. Site generation: Sat Sep 26 09:55:33 2020

	Corpus GrippeAllemagneV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeAllemagneV3

Distinction of subtype-specific antibodies against European porcine influenza viruses by indirect ELISA based on recombinant hemagglutinin protein fragment-1.

Distinction of subtype-specific antibodies against European porcine influenza viruses by indirect ELISA based on recombinant hemagglutinin protein fragment-1.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki